http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-139011-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F26B11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F26B25-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-02
filingDate 2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef11899505982995258757b9813c391
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d6e263f5211217121a0bdcb0ae8b456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c712689c4cbb8346249b2bd987b93c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54a71aef4ca2874e27ceaa532a70a01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b15ed87f587a97ef3c71d0b76ceae0
publicationDate 2009-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-139011-A
titleOfInvention Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
abstract COMPOUND OF FORMULA (1): Y N R2 O-AK-AR R3 X R4 WHEREIN: - RI, R2, R3 AND R4, WHICH MAY BE THE SAME OR DIFFERENT, EACH REPRESENT AN ATOM OR GROUP SELECTED FROM H, HALOGEN, ALKYL, ALKOXY, PHENYL AND CYANO, - X REPRESENTS A BOND, AN OXYGEN ATOM OR A GROUP SELECTED FROM -(CH2)M-, -OCH,- AND -N-R5-, WHEREIN M REPRESENTS 1 OR 2, AND R5 IS AS DEFINED IN THE DESCRIPTION, - Y REPRESENTS AN OXYGEN ATOM OR A GROUP SELECTED FROM NR7 AND CHR8, WHEREIN R7 AND R8 ARE AS DEFINED IN THE DESCRIPTION, - Z REPRESENTS A NITROGEN ATOM OR A CH GROUP, - N REPRESENTS 1 OR 2, - AK REPRESENTS AN ALKYLENE CHAIN,-AR REPRESENTS AN ARYL OR HELEROARYL GROUP, ITS OPTICAL ISOMERS, AND ALSO ADDITION SALTS THEREOF WITH A PHARMACEULICALLY ACCEPTABLE ACID.MEDICAMENTS.
priorityDate 2005-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 46.